Stephenson National Bank & Trust »

Alnylam Pharmaceuticals shares owned by Stephenson National Bank & Trust

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Stephenson National Bank & Trust from 13F filings

Historical chart of Stephenson National Bank & Trust investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Stephenson National Bank & Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Stephenson National Bank & Trust

Quarter filed Position value Share count Share price at filing
2025-09-30 $84k 185 456.00
2025-06-30 $60k 185 326.09

More positions owned by Stephenson National Bank & Trust

JPMorgan Active Value ETF Active Value Etf (JAVA)
Vanguard S&P 500 Index ETF S&p 500 Etf Shs (VOO)
JPMorgan Active Growth ETF Active Growth (JGRO)
iShares Russell Midcap Index ETF Rus Mid Cap Etf (IWR)
PIMCO Total Return Active ETF Active Bd Etf (BOND)
Fidelity Total Bond ETF Total Bd Etf (FBND)
Global Upstream Natural Resources ETF Mornstar Upstr (GUNR)
Vanguard Small-Cap ETF Small Cp Etf (VB)
Vanguard MEGA Cap ETF Mega Cap Index (MGC)
Vanguard Total Stock Market ETF Total Stk Mkt (VTI)
Vanguard Mid Cap ETF Mid Cap Etf (VO)
iShares S&P 500 Index ETF Core S&p500 Etf (IVV)
Vanguard FTSE Developed Markets Index ETF Van Ftse Dev Mkt (VEA)
iShares Russell 2000 Index ETF Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Unit (SPY)

View all positions for Stephenson National Bank & Trust

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals